drugset / Trial / NCT07300007

PK and Relative Bioavailability of Liquid Metformin vs Tablets in Healthy Adults

NCT07300007 ↗

Phase 1 Not yet recruiting 24 enrolled Aspargo Labs, Inc
NaCrossoverOpen-labelOther

Summary

The study will evaluate the pharmacokinetics and relative bioavailability of two liquid metformin formulations (100 mg/mL and 250 mg/mL)

Timeline

Start
2026-03-15
Primary completion
2026-05-15
Completion
2026-05-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule — Oral

Indications

No indication recorded.